OLATHE, Kan., April 24, 2017 -- Hooper Holmes, Inc. (NYSE MKT:HH), a leading provider of health, wellness and biometric screening services today announced the award of a new service contract with Paradigm Health Plans® the nation’s leader in the delivery of value-based health plans and health management solutions. Paradigm Health Plans will integrate Hooper Holmes’ screening services into their Lifestyle-for-Life® Health Management Program. The program is offered to Paradigm’s customers to assess participant health risks and provide health improvement tools and resources to facilitate healthier living for all.
In this strategic partnership with Paradigm Health, Hooper Holmes will offer a range of services including onsite venipuncture and finger stick testing, remote lab clinic testing, flu vaccination services and more. The core offering features a more complex 38-panel comprehensive venipuncture screening, tailored based on each participant’s age, gender, health history and test results. Administered via a single draw, this test will identify 46 critical risk factors including cardiovascular disease risks (high cholesterol); complete blood count (CBC); glucose (blood sugar) and diabetes; liver and kidney disease and functions; anemia; blood, bone, and muscle disease (including certain types of cancer); uric acid; electrolytes; and more. Traditional biometric screening panels are also available. Services are scheduled to kick-off in mid-April.
“As a company that creates flexible plan design for employers, we have unique needs and requirements. Hooper’s expertise, extensive network of credentialed health professionals and the company’s capability and willingness to administer complex blood panels and co-brand the customer experience were all key factors in the selection process,” said Dennis Labrasca, Chief Executive Officer for Paradigm. “By offering participants a snapshot into their health status, coupled with our robust Lifestyle-for-Life Health Management Program tools and education, we empower employers and employees to become active partners in managing health and healthcare condition/s costs.”
“We commend Paradigm Health Plans for their efforts to provide consumers the tools to make the most of their health and well-being,” said Henry Dubois, President and CEO of Hooper Holmes. “As we have ramped up our service model and delivered exceptional quality and satisfaction performance metrics across the book of business, Hooper is well-positioned to execute on Paradigm’s goal to leverage screenings as a meaningful face-to-face interaction, building confidence in the wellness program overall and generating interest for continued engagement post-screening.”
Onsite screenings will feature Hooper’s nationwide health professional network and technology platforms including its proprietary end-to-end event planning and scheduling system, ScreeningProTM tablet technology with online/offline paperless sign-in capabilities, participant portals and single-sign-on functionality.
About Paradigm Health
Founded in 2007, Paradigm Health Plans, LLC® (www.paradigmhealthplans.org), is a leader in self-insured health plans nationally. Paradigm Health Plans, LLC is a subsidiary of Paradigm Health Holdings, LLC, who has an integrated delivery and product portfolio focusing on insurance, reinsurance, risk solutions and self-funded products and services, the Member 360 Program® and Lifestyle-for-Life® Health Management Program (www.lifestyleforlife.com). Paradigm Health Plans are headquartered in Portsmouth, NH with employees nationwide.
About Hooper Holmes
Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs. www.hooperholmes.com
This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intends," "plan," and "will" or, in each case, their negative, and other variations or comparable terminology. These forward-looking statements include all statements other than historical facts. Any forward-looking statement made by management during this call is not a guarantee of future performance, and actual results may differ materially from those expressed in or suggested by the forward-looking statements, as a result of various factors, including, without limitation the factors discussed in the "Risk Factors" section of the company's Annual Report on Form 10-K for the year ended December 31, 2015, as the same may be updated from time-to-time in subsequent filings with the Securities and Exchange Commission. Any forward-looking statement made by management on this call speaks only as of the date hereof, and the Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. In addition, management uses the non-GAAP performance measures EBITDA and Adjusted EBITDA in this press release.
For further information: Hooper Holmes Henry E. Dubois President and CEO (913) 764-1045 Investors: Andrew Berger S.M. Berger & Company (216) 464-6400 Investors: Scott Gordon CORE IR (516) 222-2560


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Instagram Outage Disrupts Thousands of U.S. Users
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



